2021
DOI: 10.15562/ism.v12i2.995
|View full text |Cite
|
Sign up to set email alerts
|

Terapi non bedah pada karsinoma sel basal

Abstract: Basal cell carcinoma accounts for approximately 75% of non-melanoma skin cancer and 25% of all diagnosed skin cancer in the United States. Epidemiological data show the incidence is increasing significantly by 3% -10% per year worldwide. Changes in life expectancy patterns are associated with an increase in this skin cancer, and the incidence is predicted to increase until 2040. Many factors must be considered in the choice of therapy for a patient, including the patient's general condition, the presence or ab… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0
1

Year Published

2022
2022
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 14 publications
0
1
0
1
Order By: Relevance
“…Additional types include: adenoid basal cell carcinoma, pigmented basal cell carcinoma, differentiated squamous BCC (metatypical type), clear cell basal cell carcinoma, eccrine-differentiated basal cell carcinoma, and basal cell carcinoma with nuclear pleomorphism. 18 Generally carried out with local therapy, it can be surgical and nonsurgical therapy (low degree of basal cell carcinoma metastases). Surgical treatment may include curettage and electrodesiccation, cryosurgery, surgical exci-sion, and Mohs excision.…”
Section: Case Presentationmentioning
confidence: 99%
“…Additional types include: adenoid basal cell carcinoma, pigmented basal cell carcinoma, differentiated squamous BCC (metatypical type), clear cell basal cell carcinoma, eccrine-differentiated basal cell carcinoma, and basal cell carcinoma with nuclear pleomorphism. 18 Generally carried out with local therapy, it can be surgical and nonsurgical therapy (low degree of basal cell carcinoma metastases). Surgical treatment may include curettage and electrodesiccation, cryosurgery, surgical exci-sion, and Mohs excision.…”
Section: Case Presentationmentioning
confidence: 99%
“…KSB tipe campuran merupakan tipe KSB yang agresif. [16][17][18] Rekurensi dapat timbul karena adanya sisa tumor pada batas lesi setelah eksisi. Angka rekurensi pada bedah eksisi tanpa kontrol margin secara mikroskopik adalah 3,1% sampai 6,8% dalam waktu 5 tahun.…”
Section: Case Reportunclassified